Rep. Diana Harshbarger

Maddy summaryHR 196, the Family and Small Business Taxpayer Protection Act, rescinds unobligated funds previously allocated to the Internal Revenue Service (IRS) under the Inflation Reduction Act of 2022. Specifically, it directs the cancellation of unused balances from six specific funding categories within the IRS's budget as of the bill's enactment date. This action reduces the IRS's available funding without creating new tax policies or altering taxpayer obligations. The bill is procedural, focusing solely on redirecting existing, unspent government funds rather than changing tax laws or affecting individual taxpayers directly.

Maddy summaryThe FOCA Act of 2023 requires federal agencies to stop mandating or banning contractor agreements with labor organizations (like union contracts) in construction project bids and contracts. It directly affects federal contractors, subcontractors, and agencies managing construction projects funded by the government. The bill prohibits favoring or penalizing contractors based on their labor affiliation status, aiming to promote fair competition and reduce costs. It also mandates updates to federal contracting rules within 60 days of enactment to implement these changes.

Maddy summaryThis bill exempts specific orally administered drugs from Medicare Part D's manufacturer discount program. It targets drugs that: (1) received FDA approval under section 505 of the Federal Food, Drug, and Cosmetic Act, and (2) were granted a narrow CMS exception allowing reclassification as noninnovator drugs under Medicaid. The change modifies Medicare Part D rules to exclude these qualifying drugs from required manufacturer discounts. This directly affects Medicare Part D beneficiaries and drug manufacturers selling these specific medications. The policy change clarifies which drugs are subject to the discount program under existing law.

Maddy summaryHR 10050 requires the Health and Human Services Secretary to study pharmacy benefit manager (PBM) audit practices within one year of enactment. The study will assess financial impacts on independent pharmacies, evaluate if audit deadlines align with medication shelf lives (including FDA-approved 2+ year shelf lives), and examine audit transparency. It will also identify fairer audit processes to reduce burdens on pharmacists while maintaining audit integrity. The report must cover audits for Medicare, Medicaid, and insurance plans, including recommendations for transparency improvements.

Maddy summaryThis bill establishes a process for Medicare to set payment rates for certain pediatric medical devices used in children's care. Manufacturers of qualifying pediatric technologies (devices approved by the FDA, covered under Medicare, and designed specifically for children or used predominantly in pediatric procedures) can request the Secretary to create national payment rates under the physician fee schedule. The Secretary must then set these rates using available data like claims or pricing information, with specific deadlines for processing requests (by May 1 for same-year implementation). This affects Medicare payments for these devices but does not change coverage requirements or guarantee payment for new technologies.

Maddy summaryThe Pharmacists Fight Back Act (HR 9096) sets new rules for Pharmacy Benefits Managers (PBMs) working with federal health care programs like Medicare Part D and Medicaid. It requires PBMs to reimburse in-network pharmacies at a rate covering the drug's actual cost plus a small fee (capped at $25), and to reduce patient cost-sharing by at least 80% of rebates received from drug manufacturers. The bill bans PBMs from steering patients to specific pharmacies, charging patients more than pharmacies are paid, or using rebates to lower pharmacy payments after claims are processed. It also mandates public reporting of drug pricing data to improve transparency, ensuring patients and pharmacies receive fairer treatment under federal health programs.

Maddy summaryThe MOMS Act establishes a federal resource website called pregnancy.gov that will help pregnant and postpartum women find local services through a ZIP code-based search system. It creates grant programs to support nonprofit organizations providing services like medical care, housing assistance, and parenting support to pregnant women, while prohibiting organizations that provide or support abortion from receiving these funds. The bill also amends child support laws to allow enforcement of child support obligations for unborn children, beginning from the month of conception with the mother's consent. These provisions aim to improve access to prenatal and postnatal resources while maintaining a focus on supporting women and their families.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.

Maddy summaryThe 340B ACCESS Act amends the 340B Drug Pricing Program to strengthen oversight and ensure discounts reach vulnerable populations. It establishes new patient affordability requirements that limit out-of-pocket costs for eligible patients (e.g., $0 for those below the Federal poverty line, up to $35 for those between poverty line and 200% of poverty). The bill adds requirements for hospital child sites, contract pharmacies, and covered entities to prevent duplicate discounts, improve transparency, and creates a claims data clearinghouse to monitor program compliance. It imposes civil penalties for noncompliance, including fines up to $13,946 per violation for contract pharmacies that violate program requirements.

Maddy summaryThis bill creates a special enrollment period for people with COBRA health coverage who become eligible for Medicare Part B. It allows them to enroll in Medicare during the time they're on COBRA plus a 3-month grace period afterward, but only once in their lifetime. The bill also prevents COBRA coverage from reducing or ending benefits just because someone is eligible for Medicare but hasn't enrolled yet. It affects individuals transitioning from employer-sponsored COBRA plans to Medicare, particularly those turning 65 or becoming Medicare-eligible. The changes take effect for COBRA coverage beginning January 1, 2025.